Wellnex Life Investor Briefing – 27 April

April 27, 2022

Wellnex Life Investor Briefing – 27 April

Wellnex Life Limited (ASX: WNX) Webcast Replay

29th April, 2022

Wellnex Life Limited (ASX: WNX) is an Australian brand innovation and distribution company servicing the $10.7 billion Australian health and wellness market

As a part of our ‘The Insiders: Meet the CEOs’ series, CEO George Karafotias provides valuable insights to the company, its key markets and industry, and future prospects.

Recorded on 29th April 2022 at 12pm (AEST).

Join the next The Insider: Meet the CEOs webcast

Speak to the Reach Markets team


George Karafotias

CEO - Wellnex Life Limited (ASX: WNX)

Wellnex Life is a fast-growing company that is seeing significant growth in revenue, with December half-year revenue increasing 1099% from the prior corresponding period, and projected to exceed $21 million in revenue in FY22 – more than 200% from FY18. The company has a ‘first-to-market’ strategy, a large portfolio of licensed and inhouse brands and a nationwide distribution network that includes Chemist Warehouse, Woolworths and more. The company recently signed an agreement with global health powerhouse GlaxoSmithKline to supply its existing soft gel liquid analgesic in Australia and New Zealand for a minimum of three years.

Speak to the Reach Markets team

What is a 708 investor?

By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.